Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

QR Code

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Format:	Article
Language:	Russian
Published:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Series:	Проблемы особо опасных инфекций
Subjects:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Online Access:	https://journal.microbe.ru/jour/article/view/254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
by: A. A. Petrov, et al.
Published: (2020-05-01)

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
by: E. I. Kazachinskaya, et al.
Published: (2015-09-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
by: A. A. Sominina, et al.
Published: (2015-10-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
by: O. O. Fomenkov, et al.
Published: (2015-06-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
by: N. E. Tereshkina, et al.
Published: (2013-06-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
by: N. P. Khrapova, et al.
Published: (2015-03-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
by: I. I. Korsakova, et al.
Published: (2014-12-01)

Pharmacokinetic properties of the preparations of protein origin
by: A. A. Soldatov, et al.
Published: (2018-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
by: G. N. Leonova, et al.
Published: (2017-04-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
by: N. V. Bogacheva, et al.
Published: (2016-06-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
by: T. E. Sizikova, et al.
Published: (2015-09-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
by: N. T. Tikhonova, et al.
Published: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
by: A. N. Mokrievich, et al.
Published: (2013-12-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
by: L. Yu. Aksenova, et al.
Published: (2013-12-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
by: I. V. Lyagoskin, et al.
Published: (2018-02-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
by: А. С. Пастиря, et al.
Published: (2017-06-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
by: A. A. Lidzhieva, et al.
Published: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
by: Елена Борисовна Лукоянычева, et al.
Published: (2023-02-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
by: A. A. Lopatin, et al.
Published: (2015-09-01)

MONOCYTES AND GRANULOCYTES LIPOPOLYSACCHARIDE-CONNECTING POTENTIAL AT GRAVE'S DISEASE PATIENTS IN INTERRELATION WITH C(-159)T POLYMORPHISM OF CD14 MONOCYTES RECEPTORS
by: V. A. Beloglazov, et al.
Published: (2014-08-01)

Antikeratin antibodies in rheumatoid arthritis
by: J Zabek
Published: (2003-02-01)

The study of pharmacodynamics of a medicine based on humanized monoclonal antibodies against IL-17 in rabbit model of antigen-induced arthritis
by: A. A. Nedorubov, et al.
Published: (2018-02-01)

Experimental study of the pharmacokinetics of monoclonal antibodies to α4β1-integrin in guinea pigs
by: B. N. Krapivin, et al.
Published: (2018-02-01)

INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2016-09-01)

The role of microbial factor in the genesis of chronic endometritis
by: Yu. A. Petrov
Published: (2016-06-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
by: A. A. Petrov, et al.
Published: (2015-09-01)

Molecular Mechanisms of Ebola Virus Entry into Permissive Cells
by: T. E. Sizikova, et al.
Published: (2015-09-01)

The kit for identification of antibodies against Lassa and Ebola viruses by indirect immunofluorescence
by: L. M. Rustamova, et al.
Published: (2018-02-01)

Epidemiological Peculiarities and Clinical Features of Ebola Virus Disease in the Republic of Guinea
by: V. V. Maleev, et al.
Published: (2015-09-01)

Prospects of therapeutic action on FGFR signaling pathway
by: M. Yu. Fedyanin, et al.
Published: (2015-06-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
by: Markus H. Kainulainen, et al.
Published: (2023-12-01)

Experience of Application of the ELISA Method for Detection of Antibodies to Ebola Virus during the SAET Team Work in the Republic of Guinea
by: S. A. P’yankov, et al.
Published: (2016-09-01)

Safety and immunogenicity of IMVAMUNE®, a third-generation vaccine based on the modified vaccinia Ankara (MVA) strain
by: L. F. Stovba, et al.
Published: (2023-04-01)

Analysis of the Impact Consequent to the Emergence of Imported Ebola Virus Disease Cases in the Russian Federation
by: V. B. Kirillov, et al.
Published: (2015-09-01)

Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus
by: O. A. Polezhaeva, et al.
Published: (2021-02-01)

Immunogenicity and Clinical Efficacy Combined Vaccine against Diphtheria, Tetanus and Hepatitis B in Patients with Chronic Obstructive Pulmonary Disease
by: M. P. Kostinov, et al.
Published: (2017-08-01)

Assessment of biotechnological products specific activity
by: N. A. Alpatova, et al.
Published: (2018-02-01)

Anti-Vector Immune Response Formed after Immunization with Recombinant Vaccines Based on the Vaccinia Virus, MVA Strain
by: L. F. Stovba, et al.
Published: (2025-04-01)